AI in healthcare funding hits new high

The first half of the year has been good to the healthcare space for those startup companies looking for funding, as the sector has seen a record influx of cash, according to a recent report from CB Insights.

During the first six months of 2019, healthcare companies globally raised $26.9 billion, compared to $26.5 billion during the same time period in 2018. AI-focused companies in the space also saw a new funding high during the second quarter of the year, as investors zero in on the technology’s emerging presence.

Healthcare AI companies raised $864 million during the second quarter of the year. A significant chunk of that sum came from $200 million raised by Tempus, a data-driven precision medicine company, in May. The second quarter saw 75 deals for AI. Though this is slightly less than 78 deals in the first quarter, the values were much higher in the second quarter. First quarter funding reached $579 million for the space.

Higher funding rounds are making the news, as well. A U.K.-based AI health services company, Babylon Health, raised $550 million in a series C funding round at the beginning of August.

During the quarter for AI in healthcare, BlackThorn raised $76 million, Frontier Medicine raised $67 million, PathAI raised $60 million and Finch Therapeutics raised $53 million.

In addition to sky-high funding rounds, more money is flowing into AI companies focused on medical image processing, including PathAI, which uses AI powered tools for pathology.

For the rest of the year, deal count for venture capital-backed healthcare deals and financing is likely to reach an all-time high in 2019, CB Insights predicted. Digital health has been the predominant subsector across healthcare VC deals, making up 32% of all healthcare deals. However, that’s down from 33% in 2018, 36% in 2017 and 37% in 2016.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.